- 20th - 21st October 2025
- London, United Kingdom
​PATIENT ACCESS
WORLD CONGRESS 2025 EUROPE
Improving Patient Access for Better Health Outcomes and Quality of Life
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
WORLD CONGRESS 2025 EUROPE
Improving Patient Access for Better Health Outcomes and Quality of Life
FACILITATE LIVE is very pleased to welcome you to our upcoming PATIENT ACCESS World Congress 2025 Europe. The two-day Congress aims to build meaningful collaborations within the industry, advocacy groups, clinicians, researchers and most importantly, patients and their caregivers.
The congress focuses on “Improving Patient Access for Better Health Outcomes and Quality of Life.”
Massive investment and advances in research and development of novel therapeutics by Pharmaceutical and Biotechnology manufacturers, has resulted in the life science industry obtaining an accelerated rise in the number of drugs that have been brought to market over the past decade.
Patient access in pharma and healthcare refers to ensuring that patients can readily obtain the necessary medications and treatments they need in a timely and affordable manner. This involves a range of activities, including negotiating pricing agreements, demonstrating the clinical and economic value of treatments, and addressing barriers to access.
Patient access also refers to the convenience with which patients can obtain medical care. This encompasses everything from appointment scheduling to health record access. This idea is evolving rapidly in the digital age. Technology is a key factor in improving efficiency and effectiveness.
Patient access is really about making sure that patients can easily get the medications and treatments they need when they need them, and at a price they can afford. This involves a lot of different things, from working out pricing agreements to showing how valuable treatments are from both a clinical and economic perspective, and also tackling anything that might stand in the way of access.
Here are some key things to keep in mind: Patient Access Schemes (PASs), which are those confidential pricing deals that help make expensive drugs more affordable, and Market Access, which is pretty much the same as patient access and includes all the strategies companies use to make sure patients can get their products. It also includes negotiating with healthcare, payers and providers to set prices and coverage, demonstrating the clinical and economic benefits of products to justify their prices, addressing barriers like financial constraints or lack of awareness, focusing on patient involvement in decisions, and recognizing that patient access is always changing with new technologies and treatments.
There are indeed several challenges such as the high costs of drugs, payer strategies that limit access, geographical barriers, regulatory hurdles, and a general lack of awareness among some patients. To combat this, companies can implement discounts, patient assistance programs, innovative pricing agreements, and digital tools.
In conclusion, patient access is complex. It needs pharmaceutical companies, healthcare providers, payers, and patients to all work together so that everyone can get the care they need.
We look forward to meeting you at the Congress!
Sincerely yours,
Jocelyn Raguindin
Conference Director
Paradigm Global Events / Facilitate LiveÂ
GAIN LATEST INSIGHTS ON:
WHO SHOULD ATTEND?
This Congress is beneficial to patients, pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology, and healthcare companies.
Network with Presidents, Heads/Chiefs, VPs, Directors, and Managers in the area of:
We have been Gathering over 50 + Key Industry Expert Speakers
Director, JG Zebra Consulting, Co-Founder and CEO
Co- CEO, Realise Advocacy, Chair of trustees
CEO & Co-Founder Patient Advocacy Organisation
CEO
Chief Patient Officer
Patient Engagement Lead, EMEA
Founder and Patient Advocate
Sr Director, Pipeline Head of Immunology, GHEVO
Director Public Affairs, Northern Cluster
Innovative Value and Access Strategy
Group CEO
Researcher
Awaiting for Photo & Bio
Content Rich Program Agenda! Featuring Keynote Presentations, Stream Sessions, Panel, and Round Table Discussions.
Moderator:
Panelists:
Steve Clark, Founder and Patient Advocate, Strive for Five
Katja Berg, Global Value and Access Strategy, BBU, AstraZeneca
Marta Contente, Sr Director, Pipeline Head of Immunology, GHEVO, TEVA
Moderator:
Panelists:
Sjors van Gijzel, Researcher, Access to Medicines Foundation
Victoria Hayes, Director Public Affairs, Northern Cluster, Kyowa Kirin
Katherine Taylor, Patient Advocacy Lead, Pfizer UK
Moderator:
Panelists:
Moderator:
Panelists:
No Spam – You will only receive relevant information on Patient Access, and event updatesÂ
what people say
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.Â